´ëÇÑÀÎÅͺ¥¼Ç¿µ»óÀÇÇÐȸ Á¦32Â÷ Á¤±âÇмú´ëȸ(2ÀÏÂ÷) : 2024-05-25
±³À°ÀÏÀÚ : 2024-05-25
±³À°Àå¼Ò : ºÎ»êÇ×±¹Á¦Àü½ÃÄÁº¥¼Ç¼¾ÅÍ 5Ãþ À̺¥Æ®È¦A+B ¿Ü 1°³·ë
±³À°ÁÖÁ¦ : ´ëÇÑÀÎÅͺ¥¼Ç¿µ»óÀÇÇÐȸ Á¦32Â÷ Á¤±âÇмú´ëȸ(2ÀÏÂ÷)
ÁÖÃÖ±â°ü : ´ëÇÑ¿µ»óÀÇÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇÑÀÎÅͺ¥¼Ç¿µ»óÀÇÇÐȸ
´ã´çÀÚ : ÁÖÇýÁ¤
¿¬¶ôó : 02-465-9070
À̸ÞÀÏ : office@intervention.or.kr
±³À°Á¾·ù : ¿µ»óÀÇÇаú
Âü¼®¿¹»óÀÎ : 300¸í
Èñ¸ÁÆòÁ¡ : 4Á¡
Áö¿ª : ºÎ»ê±¤¿ª½Ã
±³À°½Ã°£ : 5 ½Ã°£ 20ºÐ
¼¼ºÎ¼ö°·á : 120,000¿ø
ºñ°í »çÀüµî·Ï-Á¤È¸¿ø50000¿ø, Àü¹®ÀÇ100000¿ø, Àü°øÀÇ(¿¬È¸ºñ³³ºÎÀÚ)¹«·á, Àü°øÀǹװøº¸ÀÇ 30000¿ø, ÁØȸ¿ø¹×±âŸ 50000¿ø/ÇöÀåµî·Ï-Á¤È¸¿ø70000¿ø, Àü¹®ÀÇ120000¿ø, Àü°øÀÇ(¿¬È¸ºñ³³ºÎÀÚ)¹«·á, Àü°øÀǹװøº¸ÀÇ 50000¿ø, ÁØȸ¿ø¹×±âŸ 70000¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 05¿ù 25ÀÏ ºÎ»êÇ×±¹Á¦Àü½ÃÄÁº¥¼Ç¼¾ÅÍ À̺¥Æ®È¦A+B 09:00~09:12 (±¸¿¬¹ßÇ¥) Outcomes of Femoral Arteriovenous Accesses for Hemodialysis: A Comparative Study of Fistulas and Grafts Á¤Á¦¿ø(¼øõÇâÀÇ´ë)
±³À°½Ã°£ 05¿ù 25ÀÏ ºÎ»êÇ×±¹Á¦Àü½ÃÄÁº¥¼Ç¼¾ÅÍ À̺¥Æ®È¦A+B 09:12~09:24 (±¸¿¬¹ßÇ¥) Comparison of computed tomography (CT) and endoscopic findings before and after vascular plug-assisted retrograde transvenous obliteration (PARTO) and assessment of treatment outcomes À̵¿±Ô(°í·ÁÀÇ´ë)
±³À°½Ã°£ 05¿ù 25ÀÏ ºÎ»êÇ×±¹Á¦Àü½ÃÄÁº¥¼Ç¼¾ÅÍ À̺¥Æ®È¦A+B 09:24~09:36 (±¸¿¬¹ßÇ¥) Balloon-occluded antegrade transvenous obliteration for refractory esophageal variceal bleeding alternative to transjugular intrahepatic portosystemic shunt creation: A single center retrospective study ½Éµ¿Àç(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 05¿ù 25ÀÏ ºÎ»êÇ×±¹Á¦Àü½ÃÄÁº¥¼Ç¼¾ÅÍ À̺¥Æ®È¦A+B 09:36~09:48 (±¸¿¬¹ßÇ¥) Safety and Efficacy of Coil Embolization of the Venous Segment of Type IIa Pelvic Arteriovenous Malformations ±Ç·Á¹Î(ÇѸ²ÀÇ´ë)
±³À°½Ã°£ 05¿ù 25ÀÏ ºÎ»êÇ×±¹Á¦Àü½ÃÄÁº¥¼Ç¼¾ÅÍ À̺¥Æ®È¦A+B 09:48~10:00 (±¸¿¬¹ßÇ¥) New treatment strategy of type IIIb Cho-Do angiographic classification of AVM: Single referral vascular anomalies center experience À̰濬(¼º±Õ°üÀÇ´ë)
ÈÞ½Ä 05¿ù 25ÀÏ ºÎ»êÇ×±¹Á¦Àü½ÃÄÁº¥¼Ç¼¾ÅÍ À̺¥Æ®È¦A+B 10:00~10:20 Coffee break ()
±³À°½Ã°£ 05¿ù 25ÀÏ ºÎ»êÇ×±¹Á¦Àü½ÃÄÁº¥¼Ç¼¾ÅÍ À̺¥Æ®È¦A+B 10:20~10:40 HD via fistula from a perspectives of nephrologist ÃÖÁؼ®(¸ñÆ÷´õÁ¶Àº³»°ú)
±³À°½Ã°£ 05¿ù 25ÀÏ ºÎ»êÇ×±¹Á¦Àü½ÃÄÁº¥¼Ç¼¾ÅÍ À̺¥Æ®È¦A+B 10:40~11:00 AVF/AVG intervention in private clinics ±è¿ëÅÂ(±¤Á̷ֹ¡ÀÇ¿ø)
±³À°½Ã°£ 05¿ù 25ÀÏ ºÎ»êÇ×±¹Á¦Àü½ÃÄÁº¥¼Ç¼¾ÅÍ À̺¥Æ®È¦A+B 11:00~11:20 When surgical revision is considered ¹è¹ÌÁÖ(ºÎ»êÀÇ´ë)
±³À°½Ã°£ 05¿ù 25ÀÏ ºÎ»êÇ×±¹Á¦Àü½ÃÄÁº¥¼Ç¼¾ÅÍ À̺¥Æ®È¦A+B 11:20~11:50 º¸°ÇÀÇ·áȯ°æ º¯È¿Í ¿µ»óÀÇÇаú ¿ÀÁÖÇü(°æÈñÀÇ´ë)
±âŸ 05¿ù 25ÀÏ ºÎ»êÇ×±¹Á¦Àü½ÃÄÁº¥¼Ç¼¾ÅÍ À̺¥Æ®È¦A+B 11:50~12:10 ÃÑȸ ()
ÈÞ½Ä 05¿ù 25ÀÏ ºÎ»êÇ×±¹Á¦Àü½ÃÄÁº¥¼Ç¼¾ÅÍ À̺¥Æ®È¦A+B 12:10~12:20 Coffee break ()
±âŸ 05¿ù 25ÀÏ ºÎ»êÇ×±¹Á¦Àü½ÃÄÁº¥¼Ç¼¾ÅÍ À̺¥Æ®È¦A+B 12:20~12:25 Luncheon Symposium Opening Remark ()
±âŸ 05¿ù 25ÀÏ ºÎ»êÇ×±¹Á¦Àü½ÃÄÁº¥¼Ç¼¾ÅÍ À̺¥Æ®È¦A+B 12:25~12:45 Recent Outcomes of Yttrium-90 Glass-Microsphere in early to intermediate stage : Global & Korea Çöµ¿È£(¼º±Õ°üÀÇ´ë)
±âŸ 05¿ù 25ÀÏ ºÎ»êÇ×±¹Á¦Àü½ÃÄÁº¥¼Ç¼¾ÅÍ À̺¥Æ®È¦A+B 12:45~13:05 Simplicity90Y : A highway to personalized dosimetry ÃÖÁø¿ì(¼¿ïÀÇ´ë)
±âŸ 05¿ù 25ÀÏ ºÎ»êÇ×±¹Á¦Àü½ÃÄÁº¥¼Ç¼¾ÅÍ À̺¥Æ®È¦A+B 13:05~13:15 Discussion ()
±âŸ 05¿ù 25ÀÏ ºÎ»êÇ×±¹Á¦Àü½ÃÄÁº¥¼Ç¼¾ÅÍ À̺¥Æ®È¦A+B 13:15~13:20 Luncheon Symposium Closing Remark ()
ÈÞ½Ä 05¿ù 25ÀÏ ºÎ»êÇ×±¹Á¦Àü½ÃÄÁº¥¼Ç¼¾ÅÍ À̺¥Æ®È¦A+B 13:20~13:40 Coffee break ()
±³À°½Ã°£ 05¿ù 25ÀÏ ºÎ»êÇ×±¹Á¦Àü½ÃÄÁº¥¼Ç¼¾ÅÍ À̺¥Æ®È¦A+B 13:40~14:00 Acute limb ischemia: overview from IR perspective, Treatment with CDT ±èÁØ°ï, Á¶¼ö¹ü(¼º±Õ°üÀÇ´ë, ÀÌÈÀÇ´ë)
±³À°½Ã°£ 05¿ù 25ÀÏ ºÎ»êÇ×±¹Á¦Àü½ÃÄÁº¥¼Ç¼¾ÅÍ À̺¥Æ®È¦A+B 14:00~14:20 Treatment with other PMT methods, surgical thromboembolectomy Á¶¿µÁ¾, °íÈ£Çö(¿ï»êÀÇ´ë, ÇѸ²ÀÇ´ë)
±âŸ 05¿ù 25ÀÏ ºÎ»êÇ×±¹Á¦Àü½ÃÄÁº¥¼Ç¼¾ÅÍ À̺¥Æ®È¦A+B 14:20~14:50 Strategy for acute limb ischemia Case À±Á¾Çõ, ±è°ÇÇÏ, °Ã¤ÈÆ(°í½ÅÀÇ´ë, ¿ï»êÀÇ´ë, À»ÁöÀÇ´ë)
Åä·Ð 05¿ù 25ÀÏ ºÎ»êÇ×±¹Á¦Àü½ÃÄÁº¥¼Ç¼¾ÅÍ À̺¥Æ®È¦A+B 14:50~15:00 Discussion ()
ÈÞ½Ä 05¿ù 25ÀÏ ºÎ»êÇ×±¹Á¦Àü½ÃÄÁº¥¼Ç¼¾ÅÍ À̺¥Æ®È¦A+B 15:00~15:20 Coffee break ()
±³À°½Ã°£ 05¿ù 25ÀÏ ºÎ»êÇ×±¹Á¦Àü½ÃÄÁº¥¼Ç¼¾ÅÍ À̺¥Æ®È¦A+B 15:20~15:35 The Convergence of AI, Engineering, and Medicine ÇÔ¼º¿ø(°í·ÁÀÇ´ë)
±³À°½Ã°£ 05¿ù 25ÀÏ ºÎ»êÇ×±¹Á¦Àü½ÃÄÁº¥¼Ç¼¾ÅÍ À̺¥Æ®È¦A+B 15:35~15:50 Ultrasound with AR ¹Ú¼ºÁØ(°í·ÁÀÇ´ë)
±³À°½Ã°£ 05¿ù 25ÀÏ ºÎ»êÇ×±¹Á¦Àü½ÃÄÁº¥¼Ç¼¾ÅÍ À̺¥Æ®È¦A+B 15:50~16:05 Development of an integrated system for active precise delivery of embolic beads for transcatheter arterial chemoembolization ¹æµµ¿¬(Àü³²´ëÇб³)
±³À°½Ã°£ 05¿ù 25ÀÏ ºÎ»êÇ×±¹Á¦Àü½ÃÄÁº¥¼Ç¼¾ÅÍ À̺¥Æ®È¦A+B 16:05~16:20 Bile duct RFA È«ÇöÇ¥(¼º±Õ°üÀÇ´ë)
±âŸ 05¿ù 25ÀÏ ºÎ»êÇ×±¹Á¦Àü½ÃÄÁº¥¼Ç¼¾ÅÍ À̺¥Æ®È¦A+B 16:20~16:50 ½Ã»ó ¹× Æóȸ ()
±âŸ 05¿ù 25ÀÏ ºÎ»êÇ×±¹Á¦Àü½ÃÄÁº¥¼Ç¼¾ÅÍ ÄÁÆÛ·±½ºÈ¦C+D 10:20~10:40 °øµ¿°³¾÷, ´Üµ¶°³¾÷ °æÇè Á¤ÇýµÎ, ¼º³«Á¾(¼¿ï88ÀÇ¿ø, ¼¿ïº½¿µ»óÀÇÇаú)
±âŸ 05¿ù 25ÀÏ ºÎ»êÇ×±¹Á¦Àü½ÃÄÁº¥¼Ç¼¾ÅÍ ÄÁÆÛ·±½ºÈ¦C+D 10:40~10:55 ÇØ¿ÜÁøÃâ ÀÌÇõÁØ(UPMC, USA)
±âŸ 05¿ù 25ÀÏ ºÎ»êÇ×±¹Á¦Àü½ÃÄÁº¥¼Ç¼¾ÅÍ ÄÁÆÛ·±½ºÈ¦C+D 10:55~11:10 ±¹³» ´ëÇк´¿ø±Ù¹«, ºÀÁ÷ÀÇ Çöµ¿È£, Á¶Á¤Çö(¼º±Õ°üÀÇ´ë, ´ëµ¿º´¿ø)
±âŸ 05¿ù 25ÀÏ ºÎ»êÇ×±¹Á¦Àü½ÃÄÁº¥¼Ç¼¾ÅÍ ÄÁÆÛ·±½ºÈ¦C+D 11:10~11:20 Discussion ()
±³À°½Ã°£ 05¿ù 25ÀÏ ºÎ»êÇ×±¹Á¦Àü½ÃÄÁº¥¼Ç¼¾ÅÍ ÄÁÆÛ·±½ºÈ¦C+D 15:20~15:32 (±¸¿¬¹ßÇ¥) CTA and angiographic anatomy of prostatic artery in Korean population: A bicentric retrospective study À̽ÂÇö(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 05¿ù 25ÀÏ ºÎ»êÇ×±¹Á¦Àü½ÃÄÁº¥¼Ç¼¾ÅÍ ÄÁÆÛ·±½ºÈ¦C+D 15:32~15:44 (±¸¿¬¹ßÇ¥) Comparison of the efficacy of pleural and intra-abdominal drainage between a double loop drainage catheter with absence of side holes in second loop and a conventional catheter ¹Ú»ó¿µ(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 05¿ù 25ÀÏ ºÎ»êÇ×±¹Á¦Àü½ÃÄÁº¥¼Ç¼¾ÅÍ ÄÁÆÛ·±½ºÈ¦C+D 15:44~15:56 (±¸¿¬¹ßÇ¥) Packing a biloma with gelfoam slurry: an alternative treatment option for intractable bilomas unmanageable by conventional methods À̹«¼÷(°è¸íÀÇ´ë)
±³À°½Ã°£ 05¿ù 25ÀÏ ºÎ»êÇ×±¹Á¦Àü½ÃÄÁº¥¼Ç¼¾ÅÍ ÄÁÆÛ·±½ºÈ¦C+D 15:56~16:08 (±¸¿¬¹ßÇ¥) Upper tract heparin instillation for maintenance of ureteral stent patency ±è¿ë»ó(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 05¿ù 25ÀÏ ºÎ»êÇ×±¹Á¦Àü½ÃÄÁº¥¼Ç¼¾ÅÍ ÄÁÆÛ·±½ºÈ¦C+D 16:08~16:20 (±¸¿¬¹ßÇ¥) Success Rate and Technical Aspect of Primary Transvenous Retrograde Terminal Duct Cannulation ÀüÅÂÁØ(¼º±Õ°üÀÇ´ë)